The endothelial nitric oxide synthase, nitric oxide and cyclic guanosine monophosphate (eNOS-NO-cGMP) signaling pathway has also been shown to affect the progression of NAFLD to NASH. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatohepatitis.